Paper36010674
Glycosylation in Renal Cell Carcinoma: Mechanisms and Clinical Implications.
Zhu X and 8 others. Cells, 2022. Cited by 23 papers, by iCite.
Cite this record
ConductScience Library. Glycosylation in Renal Cell Carcinoma: Mechanisms and Clinical Implications. Papers, record 36010674. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36010674
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Renal Cell | Major topic |
| Kidney Neoplasms | Major topic |
| Glycosylation | |
| Glycosyltransferases | |
| Humans | |
| Polysaccharides |
Source PubMed
References125
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18287059 | Elevated globotriaosylsphingosine is a hallmark of Fabry disease. | Proc Natl Acad Sci U S A | 2008 | https://conductscience.org/library/papers/18287059 | PubMed |
| 2 | 28982386 | FUT8 promotes breast cancer cell invasiveness by remodeling TGF-β receptor core fucosylation. | Breast Cancer Res | 2017 | https://conductscience.org/library/papers/28982386 | PubMed |
| 3 | 23139422 | The plasma membrane sialidase NEU3 regulates the malignancy of renal carcinoma cells by controlling β1 integrin internalization and recycling. | J Biol Chem | 2012 | https://conductscience.org/library/papers/23139422 | PubMed |
| 4 | 28315783 | Role of protein glycosylation in cancer metastasis. | Semin Cancer Biol | 2017 | https://conductscience.org/library/papers/28315783 | PubMed |
| 5 | 20017138 | Core 2 N-acetylglucosaminyltransferase-1 expression induces aggressive potential of testicular germ cell tumor. | Int J Cancer | 2010 | https://conductscience.org/library/papers/20017138 | PubMed |
| 6 | 22027689 | MUC13 mucin augments pancreatic tumorigenesis. | Mol Cancer Ther | 2012 | https://conductscience.org/library/papers/22027689 | PubMed |
| 7 | 27975143 | Sialylation of N-glycans: mechanism, cellular compartmentalization and function. | Histochem Cell Biol | 2017 | https://conductscience.org/library/papers/27975143 | PubMed |
| 8 | 19781661 | Differential expression of alpha-2,3-sialyltransferases and alpha-1,3/4-fucosyltransferases regulates the levels of sialyl Lewis a and sialyl Lewis x in gastrointestinal carcinoma cells. | Int J Biochem Cell Biol | 2010 | https://conductscience.org/library/papers/19781661 | PubMed |
| 9 | 20020717 | Advances in the biology and chemistry of sialic acids. | ACS Chem Biol | 2010 | https://conductscience.org/library/papers/20020717 | PubMed |
| 10 | 26220087 | Downregulation of dystroglycan glycosyltransferases LARGE2 and ISPD associate with increased mortality in clear cell renal cell carcinoma. | Mol Cancer | 2015 | https://conductscience.org/library/papers/26220087 | PubMed |
| 11 | 24318988 | FUT11 as a potential biomarker of clear cell renal cell carcinoma progression based on meta-analysis of gene expression data. | Tumour Biol | 2014 | https://conductscience.org/library/papers/24318988 | PubMed |
| 12 | 22738382 | Heparanase expression and glycosaminoglycans profile in renal cell carcinoma. | Int J Urol | 2012 | https://conductscience.org/library/papers/22738382 | PubMed |
| 13 | 18220508 | Glycoconjugates as vaccines for cancer immunotherapy: clinical trials and future directions. | Anticancer Agents Med Chem | 2008 | https://conductscience.org/library/papers/18220508 | PubMed |
| 14 | 21104290 | Modulation of E-cadherin function and dysfunction by N-glycosylation. | Cell Mol Life Sci | 2011 | https://conductscience.org/library/papers/21104290 | PubMed |
| 15 | 20840587 | Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting. | FEBS J | 2010 | https://conductscience.org/library/papers/20840587 | PubMed |
| 16 | 1977660 | A cloned human cDNA determines expression of a mouse stage-specific embryonic antigen and the Lewis blood group alpha(1,3/1,4)fucosyltransferase. | Genes Dev | 1990 | https://conductscience.org/library/papers/1977660 | PubMed |
| 17 | 25665650 | Development of Globo-H cancer vaccine. | Acc Chem Res | 2015 | https://conductscience.org/library/papers/25665650 | PubMed |
| 18 | 21098518 | Current trends in the structure-activity relationships of sialyltransferases. | Glycobiology | 2011 | https://conductscience.org/library/papers/21098518 | PubMed |
| 19 | 30588245 | α-1,2-Mannosidase MAN1C1 Inhibits Proliferation and Invasion of Clear Cell Renal Cell Carcinoma. | J Cancer | 2018 | https://conductscience.org/library/papers/30588245 | PubMed |
| 20 | 12651883 | Fucose: biosynthesis and biological function in mammals. | Glycobiology | 2003 | https://conductscience.org/library/papers/12651883 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 23 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42541248 | Aberrant sialylation in cancer: From molecular mechanisms to potential therapeutics. | Genes Dis | 2026 | https://conductscience.org/library/papers/42541248 | PubMed |
| 42533401 | Beyond Sequence: Posttranslational Remodeling of Antigens in Autoimmunity. | Immunol Rev | 2026 | https://conductscience.org/library/papers/42533401 | PubMed |
| 42068672 | MT1G promotes the progression of ccRCC by suppressing ferroptosis through activation of the PI3K-AKT pathway. | Transl Oncol | 2026 | https://conductscience.org/library/papers/42068672 | PubMed |
| 41977161 | Ochratoxin A and Clear Cell Renal Cell Carcinoma: Exploring Potential Molecular Links Through Network Toxicology and Machine Learning. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41977161 | PubMed |
| 41241472 | Spatial atlasing of N-glycosylation in healthy control and clear cell renal cell carcinoma tissues linked with immune checkpoint inhibition response by MALDI mass spectrometry imaging. | Anal Chim Acta | 2025 | https://conductscience.org/library/papers/41241472 | PubMed |
| 41155476 | Constructing a Prognostic Model for Clear Cell Renal Cell Carcinoma Based on Glycosyltransferase Gene and Verification of Key Gene Identification. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41155476 | PubMed |
| 41087473 | Pregnane X receptor (PXR) as a prognostic marker and therapeutic target in kidney renal clear cell carcinoma (KIRC) via AMPK pathway regulation. | Sci Rep | 2025 | https://conductscience.org/library/papers/41087473 | PubMed |
| 40947978 | USP7 overexpression prevents the progression of clear cell renal cell carcinoma by enhancing pyroptosis via TRIP12 deubiquitination. | Cancer Biol Ther | 2025 | https://conductscience.org/library/papers/40947978 | PubMed |
| 40852041 | Glycosylation in kidney diseases. | Precis Clin Med | 2025 | https://conductscience.org/library/papers/40852041 | PubMed |
| 40002163 | K-Means Clustering of Hyperpolarised 13C-MRI Identifies Intratumoral Perfusion/Metabolism Mismatch in Renal Cell Carcinoma as the Best Predictor of the Highest Grade. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40002163 | PubMed |
| 39920744 | Comprehensive analysis of α2,3-sialyltransferases as prognostic biomarkers and immunotherapy targets in kidney renal clear cell carcinoma. | Cancer Cell Int | 2025 | https://conductscience.org/library/papers/39920744 | PubMed |
| 39830627 | Post-translational modifications and bronchopulmonary dysplasia. | Front Pediatr | 2024 | https://conductscience.org/library/papers/39830627 | PubMed |
| 39524749 | Construction and experimental verification of a novel nine-glycosylation-related gene prognostic risk model for clear cell renal carcinoma. | Heliyon | 2024 | https://conductscience.org/library/papers/39524749 | PubMed |
| 39513119 | DOK1 facilitates the advancement of ccRCC. | J Cancer | 2024 | https://conductscience.org/library/papers/39513119 | PubMed |
| 39507262 | High RRM2 Correlates with Mitochondrial and Immune Responses in the Eosinophilic Subtype of Clear Cell Renal Cell Carcinoma. | J Inflamm Res | 2024 | https://conductscience.org/library/papers/39507262 | PubMed |
| 39245709 | GALNT6 promotes bladder cancer malignancy and immune escape by epithelial-mesenchymal transition and CD8+ T cells. | Cancer Cell Int | 2024 | https://conductscience.org/library/papers/39245709 | PubMed |
| 39105355 | N-acetylgalactosaminyltransferase GALNT6 is a potential therapeutic target of clear cell renal cell carcinoma progression. | Cancer Sci | 2024 | https://conductscience.org/library/papers/39105355 | PubMed |
| 38515689 | Identification of prognostic models for glycosylation-related subtypes and tumor microenvironment infiltration characteristics in clear cell renal cell cancer. | Heliyon | 2024 | https://conductscience.org/library/papers/38515689 | PubMed |
| 38281033 | Noninvasive serum N-glycans associated with ovarian cancer diagnosis and precancerous lesion prediction. | J Ovarian Res | 2024 | https://conductscience.org/library/papers/38281033 | PubMed |
| 37213288 | Mitochondrial metabolic reprogramming-mediated immunogenic cell death reveals immune and prognostic features of clear cell renal cell carcinoma. | Front Oncol | 2023 | https://conductscience.org/library/papers/37213288 | PubMed |
Genes74
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36010674
GET https://conductscience.org/api/papers/v1/36010674/references?page=2